| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2019 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CRINETICS PHARMACEUTICALS IN | 7 | Q2 2024 | 14.0% |
| CYTOKINETICS INC | 7 | Q2 2024 | 14.3% |
| KALVISTA PHARMACEUTICALS INC | 7 | Q2 2024 | 8.5% |
| ASCENDIS PHARMA A/S - ADR | 7 | Q2 2024 | 6.6% |
| ITEOS THERAPEUTICS INC | 7 | Q2 2024 | 5.8% |
| MORPHIC HOLDING INC | 7 | Q2 2024 | 6.9% |
| CYMABAY THERAPEUTICS INC | 5 | Q4 2023 | 10.6% |
| ARGENX SE | 5 | Q2 2024 | 10.4% |
| BIOGEN INC(NSM) | 5 | Q4 2023 | 7.8% |
| COGENT BIOSCIENCES INC | 5 | Q2 2024 | 7.5% |
View Saturn V Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-09 |
View Saturn V Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.